BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mujal A, Sola J, Hernandez M, Villarino M, Baylina M, Tajan J, Oristrell J. Safety and effectiveness of outpatient parenteral antimicrobial therapy in older people. J Antimicrob Chemother 2016;71:1402-7. [DOI: 10.1093/jac/dkv478] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Brzozowski K, Datta R, Canterino J, Malinis M, Juthani-Mehta M. Adverse Events and Healthcare Utilization Associated With Outpatient Parenteral Antimicrobial Therapy Among Older Versus Younger Adults. Open Forum Infect Dis 2020;7:ofaa358. [PMID: 33094112 DOI: 10.1093/ofid/ofaa358] [Reference Citation Analysis]
2 Durojaiye OC, Bell H, Andrews D, Ntziora F, Cartwright K. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service. Int J Antimicrob Agents 2018;51:26-32. [PMID: 28673610 DOI: 10.1016/j.ijantimicag.2017.03.016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 8.5] [Reference Citation Analysis]
3 Trentadue MB, Rafter D, Weiss S, Phelan CH. Utilizing an Evidence-Based Practice Approach to Examining Infusion Therapy Practices in Non-hospital Outpatient Ambulatory Clinic Settings. J Infus Nurs 2020;43:351-6. [PMID: 33141796 DOI: 10.1097/NAN.0000000000000394] [Reference Citation Analysis]
4 Frieler S, Hanusrichter Y, Bellova P, Geßmann J, Schildhauer TA, Baecker H. Facing multidrug-resistant pathogens in periprosthetic joint infections with self-administered outpatient parenteral antimicrobial therapy-A prospective cohort study. J Orthop Res 2021;39:320-32. [PMID: 33174643 DOI: 10.1002/jor.24906] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 O'Callaghan K, Tapp S, Hajkowicz K, Legg A, McCarthy KL. Outcomes of patients with a history of injecting drug use and receipt of outpatient antimicrobial therapy. Eur J Clin Microbiol Infect Dis 2019;38:575-80. [PMID: 30680563 DOI: 10.1007/s10096-018-03461-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Benini A, Gottardo R, Chiamulera C, Bertoldi A, Zamboni L, Lugoboni F. Continuous Infusion of Flumazenil in the Management of Benzodiazepines Detoxification. Front Psychiatry 2021;12:646038. [PMID: 33815177 DOI: 10.3389/fpsyt.2021.646038] [Reference Citation Analysis]
7 Underwood J, Marks M, Collins S, Logan S, Pollara G. Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy. J Antimicrob Chemother 2019;74:787-90. [PMID: 30462237 DOI: 10.1093/jac/dky474] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
8 Smismans A, Vantrappen A, Verbiest F, Indevuyst C, Van den Poel B, von Winckelmann S, Peeters A, Ombelet S, Lybeert P, Heremans A, Frans E, Ho E, Frans J. OPAT: proof of concept in a peripheral Belgian hospital after review of the literature. Acta Clin Belg 2018;73:257-67. [PMID: 29385901 DOI: 10.1080/17843286.2018.1424503] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Norris AH, Shrestha NK, Allison GM, Keller SC, Bhavan KP, Zurlo JJ, Hersh AL, Gorski LA, Bosso JA, Rathore MH, Arrieta A, Petrak RM, Shah A, Brown RB, Knight SL, Umscheid CA. 2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy. Clin Infect Dis 2019;68:e1-e35. [PMID: 30423035 DOI: 10.1093/cid/ciy745] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 72.0] [Reference Citation Analysis]
10 Shrestha NK, Blaskewicz C, Gordon SM, Everett A, Rehm SJ. Safety of Outpatient Parenteral Antimicrobial Therapy in Nonagenarians. Open Forum Infect Dis 2020;7:ofaa398. [PMID: 33033731 DOI: 10.1093/ofid/ofaa398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Watkins RR, Yendewa G, Burdette SD, Horattas S, Haller NA, Mangira C, Salata RA, Bonomo RA. DISC: Describing Infections of the Spine treated with Ceftaroline. J Glob Antimicrob Resist 2018;13:146-51. [PMID: 29337085 DOI: 10.1016/j.jgar.2018.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
12 Ponce González MA, Mirón Rubio M, Mujal Martinez A, Estrada Cuxart O, Fiuza Perez D, Salas Reinoso L, Fernández Fabrellas E, Chiner Vives E. Effectiveness and safety of outpatient parenteral antimicrobial therapy in acute exacerbation of chronic obstructive pulmonary disease. Int J Clin Pract 2017;71. [PMID: 28949430 DOI: 10.1111/ijcp.13022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Rae N, Kenny C, Muldoon EG. Can intravenous antifungal therapy be safely used in the outpatient parenteral antimicrobial therapy (OPAT) setting? Mycoses 2019;62:196-203. [PMID: 30499620 DOI: 10.1111/myc.12874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
14 Sriskandarajah S, Hobbs J, Roughead E, Ryan M, Reynolds K. Safety and effectiveness of 'hospital in the home' and 'outpatient parenteral antimicrobial therapy' in different age groups: A systematic review of observational studies. Int J Clin Pract 2018;:e13216. [PMID: 29920884 DOI: 10.1111/ijcp.13216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
15 Keller SC, Williams D, Gavgani M, Hirsch D, Adamovich J, Hohl D, Gurses AP, Cosgrove SE. Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy. Clin Infect Dis 2018;66:11-9. [PMID: 29020202 DOI: 10.1093/cid/cix733] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]